In the last few years, the genetic contribution to Parkinson's disease has
gained major attention and resulted in the identification of four gene loci
in autosomal dominant and autosomal recessive Parkinson's disease. Several
mutations in two genes have been shown to be responsible for neuronal cell
death in Parkinsons's disease. One of the gene products involved,alpha-syn
uclein, isa major component of Lewy bodies, the neuropathological feature o
f Parkinson's disease. In contrast, mutations in the parkin gene are associ
ated with parkinsonism without Lewy body pathology. The elucidation of poly
genic changes in the dopamine pathway, mitochondrial dysfunction, and of xe
nobiotic metabolism is technically now possible by means of association and
genotype studies. The increasing knowledge of the pathogenesis of Parkinso
n's disease at a molecular level will have important implications for the d
evelopment of individual therapeutic strategies to prevent disease progress
ion.